New hope for eradication of HIV from the body: the role of polymeric nanomedicines in HIV/AIDS pharmacotherapy

Polymeric Nanoparticles Containing Combination Antiretroviral Drugs for HIV Type 1 Treatment

(2013) Annemarie Shibata et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Dendrimers as Potential Therapeutic Tools in HIV Inhibition

(2013) Jianqing Peng et al.   MOLECULES

Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures

(2013) Isabella Bon et al.   PLoS One

Nanotechnology and the Treatment of HIV Infection

(2012) Raveen Parboosing et al.   Viruses-Basel

Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1

(2011) Sushama Telwatte et al.   ANTIVIRAL RESEARCH

Systemic Administration of Combinatorial dsiRNAs via Nanoparticles Efficiently Suppresses HIV-1 Infection in Humanized Mice

(2011) Jiehua Zhou et al.   MOLECULAR THERAPY

Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice

(2010) C. J. Destache et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs

(2009) Puneet Sharma et al.   ADVANCED DRUG DELIVERY REVIEWS

Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability

(2009) Diego A Chiappetta et al.   Nanomedicine

Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA

(2009) Kim A. Woodrow et al.   NATURE MATERIALS